Author: Richard Atkins

Richard Atkins is a senior contributor at Tech Insider covering online media, online travel, and video games. Richard has been with Tech Insider covering companies in these industries since 2011 and has authored numerous industry reports, including "Internet Video: Field of Dreams or Nightmare on Elm Street," "The Next Leg of Online Travel," and "Pwned: How Casual Games Changed The Gaming Landscape." Atkins was recognized as the No. 2 stock picker and earnings estimator in the 2011 Financial Times / StarMine Internet & Catalog Retail category and was ranked in the 2010 Wall Street Journal "Best On The Street" for the Leisure Goods & Services category.
Finance, Software

Bitcoin Review: Isle of Man Bitcoin Conference Day One

Crypto Valley Summit, a two-day conference aimed at launching the Isle of Man as a prime location for bitcoin businesses, kicked off today in the wake of news that threatened to undermine its central goal. Just one day before the conference of more than 200 attendees began, a firm providing banking facilities to bitcoin businesses on the island announced it would close those accounts under … Continue reading Bitcoin Review: Isle of Man Bitcoin Conference Day One

Richard Atkins
Finance, Internet

Stock in News: Microsoft (NASDAQ MSFT) Increases Dividends after Board Reshuffle

It’s beginning to feel as though nothing is meant to remain the same under new CEO Satya Nadella. After replacing former CEO Steve Ballmer, he’s seen his predecessor not only his post but also leave the board in order to look after his billion dollar Los Angeles Clippers, he’s decided that Microsoft Corporation (NASDAQ MSFT) software products should be made available for all devices (Office … Continue reading Stock in News: Microsoft (NASDAQ MSFT) Increases Dividends after Board Reshuffle

Richard Atkins
Finance, Mobile

Stock in Focus: Apple (NASDAQ AAPL) scores Approvals in China

Apple Inc (NASDAQ AAPL) just won two regulatory approvals for the new iPhone 6 in China. This report comes from the Ministry of Industry and Information Technology. Apple won two big regulatory approvals for the iPhone 6 which means the company is one step closer to selling the new phone in China. According to this report, four iPhone 6 models passed the China Compulsory Certification … Continue reading Stock in Focus: Apple (NASDAQ AAPL) scores Approvals in China

Richard Atkins
Finance, Internet

Stock Highlight: What Android One Could Mean to Google (NASDAQ GOOG)

Google announced the launch of its Android One platform on Monday, September 15, targeting the low-end smartphone segment in emerging markets. While newly launched phones are currently available in India, the company plans to roll them out to other developing countries such as Indonesia, the Philippines, Bangladesh, Nepal, Pakistan and Sri Lanka in the coming months. The wide launch strategy signals that the competition in … Continue reading Stock Highlight: What Android One Could Mean to Google (NASDAQ GOOG)

Richard Atkins
Finance, Internet

Facebook (NASDAQ FB) Stock News: Facebook Set To Benefit Most From Ad Dollar Shift

Facebook Inc (NASDAQ FB) is expected to emerge as the greatest beneficiary of the ad dollars that are switching from the traditional media to online platforms while Twitter Inc (NYSE TWTR) should come in second, according to a September 16th report from Cantor Fitzerald analysts Youssef Squali, Naved Khan and Kip Paulson. The conclusion is based on an analysis of top U.S. social media platforms … Continue reading Facebook (NASDAQ FB) Stock News: Facebook Set To Benefit Most From Ad Dollar Shift

Richard Atkins
Biotech Stock Finance Bio Tech
BioTech, Finance

Biotech Stocks Update: A Review of the Biotech Stocks for the Week

AbbVie (ABBV) was in the news last week thanks to its agreements with Infinity Pharmaceuticals (INFI) and Calico. Keryx Biopharmaceuticals (KERX) was also in the headlines – the company’s shares declined despite receiving FDA approval for its oral, ferric iron-based compound. Gilead (GILD) was in the news as well, once again due to its hepatitis C virus (HCV) treatment, Sovaldi. AbbVie was very active on … Continue reading Biotech Stocks Update: A Review of the Biotech Stocks for the Week

Richard Atkins